Annual Net Margin
-74.34%
-54.68%-278.13%
31 December 2023
Summary:
Emergent BioSolutions annual net profit margin is currently -74.34%, with the most recent change of -54.68% (-278.13%) on 31 December 2023. During the last 3 years, it has fallen by -95.25% (-455.52%). EBS annual net margin is now -260.42% below its all-time high of 46.34%, reached on 31 December 2002.EBS Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Margin
40.45%
+154.56%+135.45%
30 September 2024
Summary:
Emergent BioSolutions quarterly net profit margin is currently 40.45%, with the most recent change of +154.56% (+135.45%) on 30 September 2024. Over the past year, it has increased by +140.22% (+140.54%). EBS quarterly net margin is now -47.81% below its all-time high of 77.51%, reached on 31 December 2011.EBS Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EBS Net Margin Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -278.1% | +140.5% |
3 y3 years | -455.5% | +486.0% |
5 y5 years | -936.2% | +158.6% |
EBS Net Margin High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -455.5% | at low | at high | +134.3% |
5 y | 5 years | -455.5% | at low | at high | +134.3% |
alltime | all time | -260.4% | at low | -47.8% | +134.3% |
Emergent BioSolutions Net Margin History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | 40.45%(-135.4%) |
June 2024 | - | -114.11%(-3804.9%) |
Mar 2024 | - | 3.08%(-116.8%) |
Dec 2023 | -74.34%(+278.1%) | -18.34%(-81.6%) |
Sept 2023 | - | -99.77%(+26.5%) |
June 2023 | - | -78.90%(-33.1%) |
Mar 2023 | - | -118.00%(+468.9%) |
Dec 2022 | -19.66%(-246.8%) | -20.74%(-47.0%) |
Sept 2022 | - | -39.15%(+63.4%) |
June 2022 | - | -23.96%(+1832.3%) |
Mar 2022 | - | -1.24%(-104.4%) |
Dec 2021 | 13.39%(-36.0%) | 28.08%(-367.9%) |
Sept 2021 | - | -10.48%(-945.2%) |
June 2021 | - | 1.24%(-94.3%) |
Mar 2021 | - | 21.67%(-34.6%) |
Dec 2020 | 20.91%(+277.4%) | 33.12%(+201.4%) |
Sept 2020 | - | 10.99%(-56.0%) |
June 2020 | - | 24.98%(-439.4%) |
Mar 2020 | - | -7.36%(-152.8%) |
Dec 2019 | 5.54%(-37.7%) | 13.95%(-10.8%) |
Sept 2019 | - | 15.64%(-432.8%) |
June 2019 | - | -4.70%(-69.5%) |
Mar 2019 | - | -15.39%(+976.2%) |
Dec 2018 | 8.89%(-47.2%) | -1.43%(-110.6%) |
Sept 2018 | - | 13.45%(-45.3%) |
June 2018 | - | 24.60%(-611.4%) |
Mar 2018 | - | -4.81%(-125.2%) |
Dec 2017 | 16.84%(+12.3%) | 19.09%(-24.2%) |
Sept 2017 | - | 25.19%(+335.1%) |
June 2017 | - | 5.79%(-45.0%) |
Mar 2017 | - | 10.53%(-70.7%) |
Dec 2016 | 15.00%(-11.2%) | 35.92%(+87.6%) |
Sept 2016 | - | 19.15%(-202.3%) |
June 2016 | - | -18.72%(-434.9%) |
Mar 2016 | - | 5.59%(-77.4%) |
Dec 2015 | 16.90%(+43.8%) | 24.71%(-13.8%) |
Sept 2015 | - | 28.67%(+84.8%) |
June 2015 | - | 15.51%(-122.0%) |
Mar 2015 | - | -70.48%(-317.5%) |
Dec 2014 | 11.75%(-2.7%) | 32.40%(+39.4%) |
Sept 2014 | - | 23.25%(+304.3%) |
June 2014 | - | 5.75%(-110.9%) |
Mar 2014 | - | -52.57%(-395.8%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2013 | 12.07%(+10.7%) | 17.77%(+0.5%) |
Sept 2013 | - | 17.68%(+10.6%) |
June 2013 | - | 15.98%(-160.2%) |
Mar 2013 | - | -26.56%(-222.6%) |
Dec 2012 | 10.90%(-4.1%) | 21.66%(+76.8%) |
Sept 2012 | - | 12.25%(-14.7%) |
June 2012 | - | 14.36%(-172.2%) |
Mar 2012 | - | -19.88%(-125.6%) |
Dec 2011 | 11.37%(-44.7%) | 77.51%(+2836.0%) |
Sept 2011 | - | 2.64%(-83.6%) |
June 2011 | - | 16.12%(-114.0%) |
Mar 2011 | - | -115.45%(-401.1%) |
Dec 2010 | 20.57%(+55.1%) | 38.34%(+116.2%) |
Sept 2010 | - | 17.73%(+12.4%) |
June 2010 | - | 15.78%(+192.8%) |
Mar 2010 | - | 5.39%(-31.5%) |
Dec 2009 | 13.26%(+14.5%) | 7.87%(+259.4%) |
Sept 2009 | - | 2.19%(-89.2%) |
June 2009 | - | 20.28%(+17.7%) |
Mar 2009 | - | 17.23%(+323.3%) |
Dec 2008 | 11.58%(-7.7%) | 4.07%(-77.8%) |
Sept 2008 | - | 18.35%(+340.0%) |
June 2008 | - | 4.17%(-74.6%) |
Mar 2008 | - | 16.44%(-46.9%) |
Dec 2007 | 12.54%(-16.0%) | 30.95%(+374.7%) |
Sept 2007 | - | 6.52%(-130.5%) |
June 2007 | - | -21.40%(+110.4%) |
Mar 2007 | - | -10.17%(-133.8%) |
Dec 2006 | 14.92%(+23.5%) | 30.07%(+191.4%) |
Sept 2006 | - | 10.32%(-303.6%) |
June 2006 | - | -5.07%(0.0%) |
Mar 2006 | - | -5.07%(-123.3%) |
Dec 2005 | 12.08%(-12.1%) | 21.77%(+202.8%) |
Sept 2005 | - | 7.19%(0.0%) |
June 2005 | - | 7.19%(0.0%) |
Mar 2005 | - | 7.19%(-47.7%) |
Dec 2004 | 13.74%(+72.0%) | 13.74%(0.0%) |
Sept 2004 | - | 13.74%(0.0%) |
June 2004 | - | 13.74%(0.0%) |
Mar 2004 | - | 13.74% |
Dec 2003 | 7.99%(-82.8%) | - |
Dec 2002 | 46.34%(-3898.4%) | - |
Dec 2001 | -1.22% | - |
FAQ
- What is Emergent BioSolutions annual net profit margin?
- What is the all time high annual net margin for Emergent BioSolutions?
- What is Emergent BioSolutions annual net margin year-on-year change?
- What is Emergent BioSolutions quarterly net profit margin?
- What is the all time high quarterly net margin for Emergent BioSolutions?
- What is Emergent BioSolutions quarterly net margin year-on-year change?
What is Emergent BioSolutions annual net profit margin?
The current annual net margin of EBS is -74.34%
What is the all time high annual net margin for Emergent BioSolutions?
Emergent BioSolutions all-time high annual net profit margin is 46.34%
What is Emergent BioSolutions annual net margin year-on-year change?
Over the past year, EBS annual net profit margin has changed by -54.68% (-278.13%)
What is Emergent BioSolutions quarterly net profit margin?
The current quarterly net margin of EBS is 40.45%
What is the all time high quarterly net margin for Emergent BioSolutions?
Emergent BioSolutions all-time high quarterly net profit margin is 77.51%
What is Emergent BioSolutions quarterly net margin year-on-year change?
Over the past year, EBS quarterly net profit margin has changed by +140.22% (+140.54%)